BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 28/01/2003

MDI Pharmaceuticals Revokes FDA Registration, Citing 'Unacceptable' Inspection Findings

MDI Pharmaceuticals has revoked its FDA registration, citing 'unacceptable' inspection findings, marking the latest development in the company's struggles with regulatory compliance

Source: Federal Register — Justice DepartmentOpen original release →